Titleist Asset Management LLC Trims Stake in SPDR S&P Biotech ETF (NYSEARCA:XBI)

Titleist Asset Management LLC lessened its holdings in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 2.1% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 13,349 shares of the exchange traded fund’s stock after selling 281 shares during the period. Titleist Asset Management LLC’s holdings in SPDR S&P Biotech ETF were worth $1,202,000 at the end of the most recent reporting period.

Other hedge funds have also recently modified their holdings of the company. Mirae Asset Securities USA Inc. grew its position in SPDR S&P Biotech ETF by 66.7% in the 4th quarter. Mirae Asset Securities USA Inc. now owns 1,500,000 shares of the exchange traded fund’s stock valued at $135,090,000 after acquiring an additional 600,000 shares during the last quarter. Proficio Capital Partners LLC grew its holdings in shares of SPDR S&P Biotech ETF by 16,156.1% in the fourth quarter. Proficio Capital Partners LLC now owns 917,329 shares of the exchange traded fund’s stock worth $82,615,000 after purchasing an additional 911,686 shares during the last quarter. Raymond James Financial Inc. purchased a new position in SPDR S&P Biotech ETF in the 4th quarter worth about $55,529,000. Clearbridge Investments LLC boosted its position in SPDR S&P Biotech ETF by 20.5% in the 4th quarter. Clearbridge Investments LLC now owns 571,664 shares of the exchange traded fund’s stock valued at $51,484,000 after buying an additional 97,401 shares during the period. Finally, Whittier Trust Co. grew its stake in SPDR S&P Biotech ETF by 3.1% in the 4th quarter. Whittier Trust Co. now owns 320,740 shares of the exchange traded fund’s stock worth $28,885,000 after acquiring an additional 9,713 shares in the last quarter.

SPDR S&P Biotech ETF Stock Performance

Shares of NYSEARCA:XBI opened at $73.66 on Friday. The firm’s 50 day simple moving average is $88.13 and its 200-day simple moving average is $93.17. SPDR S&P Biotech ETF has a one year low of $73.25 and a one year high of $105.47. The firm has a market cap of $4.65 billion, a PE ratio of 11.47 and a beta of 1.00.

SPDR S&P Biotech ETF Cuts Dividend

The company also recently announced a dividend, which was paid on Wednesday, March 26th. Shareholders of record on Monday, March 24th were given a dividend of $0.0053 per share. The ex-dividend date was Monday, March 24th.

SPDR S&P Biotech ETF Company Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.